Aspira Women’s Health (NASDAQ:AWH) Now Covered by StockNews.com

StockNews.com began coverage on shares of Aspira Women’s Health (NASDAQ:AWH) in a report issued on Monday morning. The firm issued a hold rating on the stock.

Aspira Women’s Health Trading Down 6.7 %

AWH stock opened at $0.70 on Monday. The business’s fifty day moving average price is $0.78 and its 200 day moving average price is $0.97. Aspira Women’s Health has a 12-month low of $0.67 and a 12-month high of $5.65. The company has a market capitalization of $11.67 million, a PE ratio of -0.58 and a beta of 1.42.

Hedge Funds Weigh In On Aspira Women’s Health

A hedge fund recently raised its stake in Aspira Women’s Health stock. B. Riley Wealth Advisors Inc. raised its position in Aspira Women’s Health Inc. (NASDAQ:AWH) by 33.8% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 316,294 shares of the company’s stock after acquiring an additional 79,898 shares during the quarter. B. Riley Wealth Advisors Inc. owned approximately 1.90% of Aspira Women’s Health worth $256,000 as of its most recent SEC filing. Hedge funds and other institutional investors own 12.19% of the company’s stock.

Aspira Women’s Health Company Profile

Aspira Women's Health Inc, together with its subsidiaries, discovers, develops, and commercializes of noninvasive AI-powered diagnostic tests for gynecologic diseases in the United States. The company's products include Ova1Plus, a qualitative serum test to assess the likelihood of malignancy in women with an ovarian adnexal mass; Overa, a biomarker test intended to maintain Ova1's high sensitivity; and OvaWatch, a laboratory developed tests to assist in the initial clinical assessment of malignancy risk in all women thought to have an indeterminate or benign adnexal mass.